Clinical Trials Browser

Phase 2 × taletrectinib × Clear all

NCT04919811 2026-01-07

TRUST-II

Phase 2 Active not recruiting

217 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT06214793 2025-05-01

Taletrectinib in Previously Treated Metastatic CDH1-mutated Invasive Lobular Cancer (ILC)

Phase 2 Suspended

Breast Neoplasms